Mersana Talk About Fleximer-Based ADCs

LONDON - March 24, 2014 - PRLog -- SMi are pleased to announce that Mersana Chief Scientific Officer, Dr Tim Lowinger will be speaking at the 3^rd annual ADC Summit taking place on 19^th and 20^th May in Central London.

Highlights from the presentation entitled: Fleximer based ADCs will discuss:

·         Overcoming common hurdles

·         Improving DAR without Sacrificing PK and Tolerability

·         Maximizing Efficacy of ADCs Targeting Low Expression Targets

·         Broadening the Diversity of Payloads Amenable to ADCs

Mersana’s Fleximer-ADC technology provides several key advantages including: ability to deliver alternative payloads beyond anti-tubulins; opportunity to significantly increase drug loading per antibody; and potential use with antibody fragments and alternative targeting moieties in addition to monoclonal antibodies.

To hear more from Mersana, meet them at SMi's 3rd annual ADC Summit by registering online at http://www.smi-online.co.uk/pharmaceuticals/uk/conference...


How will this year’s programme aim to accelerate ADC research?

Attendees will learn about the emerging applications of nanotechnologies with updates on nanobody platforms and controlled release.

1. The manufacturing of ADC’s and selecting the right target and the right antibody will be exemplified by Polytherics Ltd, MedImmune and Photobiotics.

2. Spirogen will debate creative ways to make your “smart bomb” more intelligent when building your oncology arsenal.

3. Payload, Linker and trafficking strategies for ADC’s will be unveiled by ImmunoGen, and Pfizer

4. Genentech, Progenics and Synthon will demonstrate pre-clinical development with a focus on toxicity, correlation of exposure & therapeutic effect, vitro and in vivo studies.

5. Mersana, Sutro Biopharma, Algeta, Philochem and Regeneron will provide unique insights into the next generations of ADC’S.

For those who are interested in attending, there is currently a £100 early bird available online which expires on 31^st March. Visit http://www.smi-online.co.uk/pharmaceuticals/uk/conference/adc-summit

ADC Summit
19th & 20th May 2014 | Holiday Inn Regents Park Hotel, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/adc-summit
Sponsored by PolyTherics and Viventia Bio Inc

Note to Editor

SMi Group also offers direct access to key decision makers in this sector through tailored sponsorship and exhibitor packages. For details contact Alia Malick on tel: +44 (0)20 7827 6168 or email: amalick@smi-online.co.uk

About SMi Group
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.
We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.

More information can be found at www.smi-online.co.uk